• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幼年特发性关节炎患儿的感染是否比健康儿童更频繁?一项前瞻性多中心观察性研究。

Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study.

作者信息

Udaondo Clara, Núñez Cuadros Esmeralda, Murias Sara, Remesal Agustin, Alcobendas Rosa, Guerrero Concepción, Guillen-Martin Sara, Escuredo Marta, Aleo Esther, Alonso Daniel, Tagarro Alfredo, De Santiago Eloisa, Camacho-Lovillo Marisol, Diaz Fatima, Arenas Dolores, Camacho Pilar, Lirola Maria Jose, Díaz Almirón Mariana, Calvo Cristina

机构信息

Pediatric Rheumatology Unit, University Hospital La Paz, Madrid, Spain.

La Paz Research Institute (IDIPaz), Madrid, Spain.

出版信息

Front Pediatr. 2022 Aug 11;10:917731. doi: 10.3389/fped.2022.917731. eCollection 2022.

DOI:10.3389/fped.2022.917731
PMID:36034561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9403004/
Abstract

BACKGROUND

Children with juvenile idiopathic arthritis (JIA) might be at a higher risk of infection. Our objectives are to describe and compare infection rates in patients with JIA vs. healthy patients.

METHODS

A prospective, multicenter observational study was performed in Spain from January 2017 to June 2019. Patients with JIA from 7 participating hospitals and children without JIA (siblings of patients with JIA, and non-JIA children from primary health centers) were followed up with quarterly questionnaires to record infection episodes. Tuberculosis, herpes zoster, and infections requiring hospital admission were considered severe infections. Rates of infection (episodes/patient/year) were compared using a generalized estimating equations model.

RESULTS

A total of 371 children (181 with and 190 without JIA) were included. The median age was 8.8 years (IQR 5.5-11.3); 75% of the patients with JIA received immunosuppressive treatment (24% methotrexate, 22% biologic, 26% both). A total of 667 infections were recorded; 15 (2.2%) were considered severe. The infection rate was 1.31 (95%CI 1.1-1.5) in JIA and 1.12 (95%CI 0.9-1.3) in non-JIA participants ( = 0.19). Age <4 years increased the infection rate by 2.5 times (2.72 vs. 1.12, < 0.001) in both groups. The most frequent infection sites were upper respiratory (62.6% vs. 74.5%) and gastrointestinal (18.8% vs. 11.4%). There were no differences in severe infections (2.5% vs. 2%, = 0.65) between the groups. In children with JIA, younger age and higher disease activity (JADAS71) were associated with a higher infection rate.

CONCLUSION

We found no differences in the infection rate or infection severity between patients with and without JIA. Most infections were mild. An age younger than 4 years increased the infection risk in both groups. Higher disease activity was associated with a higher infection rate.

摘要

背景

幼年特发性关节炎(JIA)患儿可能有更高的感染风险。我们的目的是描述和比较JIA患者与健康患者的感染率。

方法

2017年1月至2019年6月在西班牙进行了一项前瞻性、多中心观察性研究。对来自7家参与研究医院的JIA患者以及无JIA的儿童(JIA患者的兄弟姐妹和初级卫生保健中心的非JIA儿童)每季度进行问卷调查,以记录感染事件。结核病、带状疱疹以及需要住院治疗的感染被视为严重感染。使用广义估计方程模型比较感染率(事件数/患者/年)。

结果

共纳入371名儿童(181名JIA患儿和190名非JIA患儿)。中位年龄为8.8岁(四分位间距5.5 - 11.3);75%的JIA患者接受免疫抑制治疗(24%使用甲氨蝶呤,22%使用生物制剂,26%两者都用)。共记录到667次感染;15次(2.2%)被视为严重感染。JIA患者的感染率为1.31(95%置信区间1.1 - 1.5),非JIA参与者的感染率为1.12(95%置信区间0.9 - 1.3)(P = 0.19)。两组中年龄<4岁者感染率增加2.5倍(2.72对1.12,P < 0.001)。最常见的感染部位是上呼吸道(62.6%对74.5%)和胃肠道(18.8%对11.4%)。两组间严重感染无差异(2.5%对2%,P = 0.65)。在JIA患儿中,年龄较小和疾病活动度较高(JADAS71)与较高的感染率相关。

结论

我们发现JIA患者与非JIA患者在感染率或感染严重程度方面没有差异。大多数感染为轻度。年龄小于4岁会增加两组的感染风险。较高的疾病活动度与较高的感染率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ec/9403004/ff3c8aeff75d/fped-10-917731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ec/9403004/ff3c8aeff75d/fped-10-917731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ec/9403004/ff3c8aeff75d/fped-10-917731-g001.jpg

相似文献

1
Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study.幼年特发性关节炎患儿的感染是否比健康儿童更频繁?一项前瞻性多中心观察性研究。
Front Pediatr. 2022 Aug 11;10:917731. doi: 10.3389/fped.2022.917731. eCollection 2022.
2
A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors.一项前瞻性研究,比较接受和未接受肿瘤坏死因子-α抑制剂治疗的幼年特发性关节炎患儿的感染风险和疾病活动情况。
Clin Rheumatol. 2015 Mar;34(3):457-64. doi: 10.1007/s10067-014-2779-8. Epub 2014 Sep 18.
3
Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.青少年特发性关节炎患者带状疱疹感染的发病率。
Rheumatol Int. 2015 Mar;35(3):465-70. doi: 10.1007/s00296-014-3197-6. Epub 2015 Jan 13.
4
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.简短报告:青少年特发性关节炎患儿中特定机会性感染的发生率
Arthritis Rheum. 2013 May;65(5):1384-9. doi: 10.1002/art.37866.
5
Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.芬兰幼年特发性关节炎儿童严重肺炎发病率呈下降趋势。
Clin Rheumatol. 2020 Mar;39(3):853-860. doi: 10.1007/s10067-019-04804-x. Epub 2019 Nov 16.
6
High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.在实际临床环境中,接受生物治疗的幼年特发性关节炎患者严重感染发生率较高。
Mod Rheumatol. 2018 Mar;28(2):264-270. doi: 10.1080/14397595.2017.1349059. Epub 2017 Sep 26.
7
Lower genital tract infections in young female juvenile idiopathic arthritis patients.年轻女性幼年特发性关节炎患者的下生殖道感染。
Adv Rheumatol. 2019 Nov 15;59(1):50. doi: 10.1186/s42358-019-0092-6.
8
Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.幼年特发性关节炎患儿患结核病的风险:台湾一项基于全国人口的研究
PLoS One. 2015 Jun 5;10(6):e0128768. doi: 10.1371/journal.pone.0128768. eCollection 2015.
9
The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis.生物制剂在幼年特发性关节炎中的必要性、疗效及安全性。
North Clin Istanb. 2019 Nov 14;7(2):118-123. doi: 10.14744/nci.2019.57873. eCollection 2020.
10
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.阿达木单抗联合甲氨蝶呤治疗与幼年特发性关节炎相关的难治性葡萄膜炎:一项 RCT。
Health Technol Assess. 2019 Apr;23(15):1-140. doi: 10.3310/hta23150.

引用本文的文献

1
Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8 T cell repertoire response to influenza vaccination.青少年特发性关节炎患者对流感疫苗的 CD8 T 细胞反应中克隆多样性降低。
Front Immunol. 2024 May 30;15:1306490. doi: 10.3389/fimmu.2024.1306490. eCollection 2024.

本文引用的文献

1
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry.真实世界中生物制剂治疗幼年特发性关节炎患者的感染风险比较:来自德国 BIKER 登记处的数据。
Rheumatol Int. 2021 Apr;41(4):751-762. doi: 10.1007/s00296-020-04774-3. Epub 2021 Feb 16.
2
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee.免疫抑制的幼年特发性关节炎患儿的机会性感染:Pharmachild 安全裁决委员会的分析。
Arthritis Res Ther. 2020 Apr 7;22(1):71. doi: 10.1186/s13075-020-02167-2.
3
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
2019 年更新版:欧洲抗风湿病联盟成人自身免疫性炎症性风湿病患者疫苗接种推荐。
Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.
4
The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis.肿瘤坏死因子-α抑制剂治疗对幼年特发性关节炎患儿感染发生率的影响:一项荟萃分析。
Pediatr Rheumatol Online J. 2019 Jan 18;17(1):4. doi: 10.1186/s12969-019-0305-x.
5
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.在接受生物制剂或合成药物治疗的幼年特发性关节炎患者中的药物警戒:来自 Pharmachild 和国家登记处的超过 15000 名患者的合并数据。
Arthritis Res Ther. 2018 Dec 27;20(1):285. doi: 10.1186/s13075-018-1780-z.
6
Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses.生物制剂治疗幼年特发性关节炎相关严重感染风险的系统评价和荟萃分析。
J Pediatr. 2019 Jan;204:162-171.e3. doi: 10.1016/j.jpeds.2018.08.065. Epub 2018 Oct 11.
7
Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study.芬兰 1999-2014 年儿童幼年特发性关节炎相关肺炎:全国回顾性登记研究。
Clin Exp Rheumatol. 2018 May-Jun;36(3):502-507. Epub 2017 Dec 27.
8
Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country.在一个结核病高风险国家,对接受抗TNF治疗前的幼年特发性关节炎患者进行潜伏性结核感染筛查。
Rev Bras Reumatol Engl Ed. 2017 Sep-Oct;57(5):392-396. doi: 10.1016/j.rbre.2016.11.004. Epub 2016 Dec 7.
9
Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.儿童幼年特发性关节炎患者使用肿瘤坏死因子-α抑制剂的严重细菌感染风险。
Rheumatology (Oxford). 2018 Feb 1;57(2):273-282. doi: 10.1093/rheumatology/kex049.
10
Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry.德国儿科风湿病生物制剂登记处中与肿瘤坏死因子抑制剂及疾病活动相关的幼年特发性关节炎患者发生严重感染的风险
Arthritis Care Res (Hoboken). 2017 Apr;69(4):552-560. doi: 10.1002/acr.22961.